96
Views
0
CrossRef citations to date
0
Altmetric
Research Article

Adipose-derived mesenchymal stromal cells from genetically modified pigs: immunogenicity and immune modulatory properties

, , , , , & show all
Pages 494-504 | Received 27 Jul 2011, Accepted 15 Dec 2011, Published online: 23 Jan 2012

References

  • Dominici M, Le Blanc K, Mueller I, Slaper-Cortenbach I, Marini F, Krause D, . Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy. 2006;8:315–17.
  • Le Blanc K, Rasmusson I, Sundberg B, Götherström C, Hassan M, Uzunel M, . Treatment of severe acute graft-versus-host disease with third party haploidentical mesenchymal stem cells. Lancet. 2004;363:1439–41.
  • Bartholomew A, Sturgeon C, Siatskas M, Ferrer K, McIntosh K, Patil S, . Mesenchymal stem cells suppress lymphocyte proliferation in vitro and prolong skin graft survival in vivo. Exp Hematol. 2002;30:42–8.
  • Zhang W, Ge W, Li C, You S, Liao L, Han Q, . Effects of mesenchymal stem cells on differentiation, maturation, and function of human monocyte-derived dendritic cells. Stem Cells Dev. 2004;13:263–71.
  • Selmani Z, Naji A, Zidi I, Favier B, Gaiffe E, Obert L . Human leukocyte antigen-G5 secretion by human mesenchymal stem cells is required to suppress T lymphocyte and natural killer function and to induce CD4 + CD25high FOXP3 + regulatory T cells. Stem Cells. 2008;26:212–22.
  • Aggarwal S, Pittenger MF. Human mesenchymal stem cells modulate allogeneic immune cell responses. Blood. 2005;105:1815–22.
  • Krampera M, Cosmi L, Angeli R, Pasini A, Liotta F, Andreini A, . Role for interferon-gamma in the immunomodulatory activity of human bone marrow mesenchymal stem cells. Stem Cells. 2006;24:386–98.
  • Miura M, Miura Y, Padilla-Nash HM, Molinolo AA, Fu B, Patel V, . Accumulated chromosomal instability in murine bone marrow mesenchymal stem cells leads to malignant transformation. Stem Cells. 200;24:1095–103.
  • Røsland GV, Svendsen A, Torsvik A, Sobala E, McCormack E, Immervoll H, . Long-term cultures of bone marrow-derived human mesenchymal stem cells frequently undergo spontaneous malignant transformation. Cancer Res. 2009;69: 5331–9.
  • Ezzelarab M, Ayares D, Cooper DK. The potential for genetically-modified pig mesenchymal stromal cells in xenotransplantation. Xenotransplantation. 2010;17:3–5.
  • Ezzelarab M, Ezzelarab C, Wilhite T, Kumar G, Hara H, Ayares D, . Genetically-modified pig mesenchymal stromal cells: xenoantigenicity and effect on human T-cell xenoresponses. Xenotransplantation. 2011;18:183–95.
  • Kern S, Eichler H, Stoeve J, Klüter H, Bieback K. Comparative analysis of mesenchymal stem cells from bone marrow, umbilical cord blood, or adipose tissue. Stem Cells. 2006;24: 1294–301.
  • Jones EA, Kinsey SE, English A, Jones RA, Straszynski L, Meredith DM, . Isolation and characterization of bone marrow multipotential mesenchymal progenitor cells. Arthritis Rheum. 2002;46: 3349–60.
  • Kilroy GE, Foster SJ, Wu X, Ruiz J, Sherwood S, Heifetz A, . Cytokine profile of human adipose-derived stem cells: expression of angiogenic, hematopoetic, and pro-inflammatory factors. J Cell Physiol. 2007;212:702–9.
  • Hara H, Long C, Lin YJ, Tai HC, Ezzelarab M, Ayares D, Cooper DKC. In vitro investigation of pig cells for resistance to human antibody-mediated rejection. Transplant Int. 2008;21:1163–74.
  • Jackson KA, Majka SM, Wang H, Pocius J, Hartley CJ, Majesky MW, . Regeneration of ischemic cardiac muscle and vascular endothelium by adult stem cells. J Clin Invest. 2001;107:1395–402.
  • Baber SR, Deng W, Master RG, Bunnell BA, Taylor BK, Murthy SN, . Intratracheal mesenchymal stem cell administration attenuates monocrotaline-induced pulmonary hypertension and endothelial dysfunction. Am J Physiol Heart Circ Physiol. 2007;292:H1120–28.
  • Gonzalez-Rey E, Anderson P, González MA, Rico L, Büscher D, Delgado M. Human adult stem cells derived from adipose tissue protect against experimental colitis and sepsis. Gut. 2009 ;58: 929–39.
  • Lin F, Cordes K, Li L, Hood L, Couser WG, Shankland SJ, . Hematopoietic stem cells contribute to the regeneration of renal tubules after renal ischemia-reperfusion injury in mice. J Am Soc Nephrol. 2003;14:1188–99.
  • McDonald JW, Liu XZ, Qu Y, Liu S, Mickey SK, Turetsky D, . Transplanted embryonic stem cells survive, differentiate and promote recovery in injured rat spinal cord. Nat Med. 1999;5:1410–12.
  • Itakura S, Asari S, Rawson J, Ito T, Todorov I, Liu CP, . Mesenchymal stem cells facilitate the induction of mixed hematopoietic chimerism and islet allograft tolerance without GVHD in the rat. Am J Transplant. 2007;7:336–46.
  • MacDonald GI, Augello A, De Bari C. Role of Mesenchymal stem cells: re-establishing immunological tolerance in autoimmune rheumatic diseases. Arthritis Rheum. 2011;63:2547–57.
  • Prockop DJ. Marrow stromal cells as stem cells for nonhematopoietic tissues. Science. 1997;276:71–4.
  • Vacanti V, Kong E, Suzuki G, Sato K, Canty JM, Lee T. Phenotypic changes of adult porcine mesenchymal stem cells induced by prolonged passaging in culture. J Cell Physiol. 2005;205:194–201.
  • Puissant B, Barreau C, Bourin P, Clavel C, Corre J, Bousquet C, . Immunomodulatory effect of human adipose tissue-derived adult stem cells: comparison with bone marrow mesenchymal stem cells. Br J Haematol. 2005;129:118–29.
  • Phelps CJ, Koike C, Vaught TD, Boone J, Wells KD, Chen SH, . Production of alpha 1,3-galactosyltransferase-deficient pigs. Science. 2003;299:411–14.
  • Truscott SM, Abate G, Price JD, Kemper C, Atkinson JP, Hoft DF. CD46 engagement on human CD4 + T cells produces T regulatory type 1-like regulation of antimycobacterial T cell responses. Infect Immun. 2010;78:5295–306.
  • Lin Y, Hara H, Tai H, Long C, Tokita D, Yeh P, . Suppressive efficacy and proliferative capacity of human regulatory T cells in allogeneic and xenogeneic responses. Transplantation. 2008;86:1452–62.
  • Ezzelarab M, Welchons D, Torres C, Hara H, Long C, Yeh P, . Atorvastatin down-regulates the primate cellular response to porcine aortic endothelial cells in vitro. Transplantation. 2008;86 :733–7.
  • Hara H, Koike N, Long C, Piluek J, Roh DS, Sundarraj N, . Initial in vitro investigation of the human immune response to corneal cells from genetically engineered pigs. Invest Ophthalmol Vis Sci 2011;52:5278–86.
  • Uccelli A, Moretta L, Pistoia V. Mesenchymal stem cells in health and disease. Nat Rev Immunol. 2008;8:726–36.
  • Weiss EH, Lilienfeld BG, Müller S, Müller E, Herbach N, Kessler B, . HLA-E/human beta2-microglobulin transgenic pigs: protection against xenogeneic human anti-pig natural killer cell cytotoxicity. Transplantation. 2009;87:35–43.
  • Forte P, Pazmany L, Matter-Reissmann UB, Stussi G, Schneider MK, Seebach JD. HLA-G inhibits rolling adhesion of activated human NK cells on porcine endothelial cells. J Immunol. 2001;167: 6002–8.
  • Hering BJ, Wijkstrom M, Graham ML, Hårdstedt M, Aasheim TC, Jie T, . Prolonged diabetes reversal after intraportal xenotransplantation of wild-type porcine islets in immunosuppressed nonhuman primates. Nat Med. 2006;12: 301–3.
  • Cardona K, Korbutt GS, Milas Z, Lyon J, Cano J, Jiang W, . Long-term survival of neonatal porcine islets in nonhuman primates by targeting costimulation pathways. Nat Med. 2006;12:304–6.
  • van der Windt DJ, Bottino R, Casu A, Campanile N, Smetanka C, He J, . Long-term controlled normoglycemia in diabetic non-human primates after transplantation with hCD46 transgenic porcine islets. Am J Transplant. 2009;9:2716–26.
  • Solari MG, Srinivasan S, Boumaza I, Unadkat J, Harb G, Garcia-Ocana A, . Marginal mass islet transplantation with autologous mesenchymal stem cells promotes long-term islet allograft survival and sustained normoglycemia. J Autoimmun. 2009;32:116–24.
  • Berman DM, Willman MA, Han D, Kleiner G, Kenyon NM, Cabrera O, . Mesenchymal stem cells enhance allogeneic islet engraftment in nonhuman primates. Diabetes. 2010;59: 2558–68.
  • Deng W, Han Q, Liao L, Li C, Ge W, Zhao Z, . Allogeneic bone marrow-derived flk-1 + Sca-1-mesenchymal stem cells leads to stable mixed chimerism and donor-specific tolerance. Exp Hematol. 2004;32: 861–7.
  • Maccario R, Podestà M, Moretta A, Cometa A, Comoli P, Montagna D, . Interaction of human mesenchymal stem cells with cells involved in alloantigen-specific immune response favors the differentiation of CD4 + T-cell subsets expressing a regulatory/suppressive phenotype. Haematologica. 2005;90:516–25.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.